MeiraGTx Holdings plc

10/01/2022 | Press release | Distributed by Public on 10/01/2022 08:05

Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associated X-linked Retinitis Pigmentosa (XLRP) Presentation